What are the potential benefits and risks associated with JAK inhibitors for psoriatic arthritis?

... psoriatic arthritis (PsA)1. CLINICAL DATA. IMPACT 2. ACR20 RESPONSE; Enthesitis; Dactylitis. At Week 14, significantly more patients receiving REMICADE® 5 mg/kg ... Jun 8, 2023 ... Psoriatic arthritis (PsA) is a typical complication of psoriasis (PSO) that is often accompanied by nail PSO, vertebral and/or pelvic ... There was only a modest impact on psoriasis lesions. Rheumatoid Arthritis. In a Phase 3b double-blind, double-dummy, 6 month study, Genovese et al, ... Feb 8, 2021 ... ... rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. However, there is increasing evidence that the drug makers failed to ... Feb 17, 2024 ... Doctors continue to study the treatment and triggers for psoriasis. Some of the areas they're pursuing for future potential treatment are: gene ... Nov 23, 2021 ... Therefore, skin involvement offers to the rheumatologist a unique opportunity to study PsA in a very early phase, having a cohort of psoriatic “ ... Psoriatic arthritis (PsA) is a type of arthritis that happens when the body's immune system attacks healthy cells and tissues causing joint pain, stiffness, ... Psoriatic Arthritis · Rheumatoid Arthritis. More About Arthritis. Related ... Informational Brochures: Juvenile Arthritis and A Teacher's Guide. Help your ... The mission of the PAPAA is to provide support and information to individuals affected by PA. Established in 1993, the alliance also monitors medical and ... All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care ...